• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23538 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     Technology Assessment at SickKids (TASK) Systematic review on orchidopexy for the Canadian Paediatric Surgical Wait Times project
2009     NIHR Health Technology Assessment programme The role of magnetic resonance imaging in the identification of suspected acoustic neuroma: systematic review of clinical and cost effectiveness, and natural history
2009     NIHR Health Technology Assessment programme Funding to cover the costs incurred to hold the 4th International Balliol Surgical Trials Colloquia
2009     HAYES, Inc. Late-onset familial alzheimer disease (AD2)
2009     Health Council of the Netherlands Gezondheidsraad (GR) General vaccination against hepatitis B revisited
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Topical diclofenac for the treatment of musculoskeletal pain unrelated to osteoarthritis: a review of the clinical effectiveness
2009     HAYES, Inc. Maturity-Onset Diabetes of the Young (MODY)
2009     Andalusian Health Technology Assessment Area (AETSA) [Internet, health and citizenship]
2009     Health Council of the Netherlands Gezondheidsraad (GR) [Pregnancy immunisation by red blood cells]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium for moderate-to-severe chronic obstructive pulmonary disease: a review of the clinical effectiveness and cost-effectiveness
2009     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Observation of technologies after their introduction into clinical practice. Prioritisation and assessment protocol proposal]
2009     HAYES, Inc. MYH-Associated Polyposis (MAP)
2009     Health Council of the Netherlands Gezondheidsraad (GR) Care for the unborn child
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Sevelamer hydrochloride for the treatment of patients with chronic kidney disease: a review of the clinical effectiveness
2009     HAYES, Inc. PathFinderTG test for pancreatic cancer
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pyxis and medDISPENSE automated medication dispensing systems: a review of the clinical benefits and harms, cost-effectiveness, and guidelines for use
2009     Norwegian Knowledge Centre for the Health Services (NOKC) [Misoprostol for induction of labour]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Portable bone mineral density scanners: a review of the clinical effectiveness
2009     Andalusian Health Technology Assessment Area (AETSA) [Report NDP disinfectant (R) Med Concentrate (N-Duopropenide). Update 2008]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological management of depression in Parkinson's disease: evidence for antidepressant of choice
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological interventions for weight loss: a review of the clinical and cost-effectiveness
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Folic acid fortification of flour in Austria - risks and benefits
2009     Andalusian Health Technology Assessment Area (AETSA) [Manual to adapt health technology assessment reports to the public (MADETSCI)]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Oxybutynin, tolterodine, and darifenacin: review of cognitive adverse events
2009     NIHR Health Technology Assessment programme Telbivudine for the treatment of chronic hepatitis B infection
2009     Health Council of the Netherlands Gezondheidsraad (GR) A national colorectal cancer screening programme
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared to fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: supplementary analyses relating to risk of infection from an unknown virus
2009     NIHR Health Technology Assessment programme Entecavir for the treatment of chronic hepatitis B infection
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Evidence supported health service planning
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) New influenza (swine flu) - data & facts for decision support
2009     Belgian Health Care Knowledge Centre (KCE) Tiotropium in the treatment of chronic obstructive pulmonary disease health technology assessment
2009     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against pandemic influenza A/H1N1 2009: target groups and prioritisation
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) n-3 lipids for patients on total parenteral nutrition: a review of the clinical and cost-effectiveness
2009     NIHR Health Technology Assessment programme Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Cetuximab (Erbitux) in EGFR-expressing Non-Small Cell Lung Cancer
2009     Belgian Health Care Knowledge Centre (KCE) Positron Emission Tomography (PET) in Belgium: an update
2009     Health Council of the Netherlands Gezondheidsraad (GR) [Prevention in the elderly: Focus on functioning in daily life]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Minimal access lobectomy for lung cancer patients: a review of the clinical and cost-effectiveness
2009     NIHR Health Technology Assessment programme Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal
2009     NIHR Health Technology Assessment programme Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Classification of disease severity for neuro- and trauma rehabilitation. Part 1: instruments for stroke and traumatic brain injury
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Everolimus (Afinitor) for advanced/metastatic kidney cancer
2009     Belgian Health Care Knowledge Centre (KCE) Pharmaceutical and non-pharmaceutical interventions for Alzheimer's Disease, a rapid assessment
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Radioimmunotherapies for non-hodgkin lymphoma: systematic review of clinical effectiveness, cost-effectiveness, and guidelines
2009     Institute of Health Economics (IHE) Human papillomavirus (HPV) testing in Alberta
2009     NIHR Health Technology Assessment programme Ustekinumab for the treatment of moderate to severe psoriasis
2009     Belgian Health Care Knowledge Centre (KCE) Pharmaceutical and nonpharmaceutical interventions for Alzheimer’s disease, a rapid assessment
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Coverage with evidence development - experiences from selected countries
2009     Belgian Health Care Knowledge Centre (KCE) Policies for rare diseases and orphan drugs
2009     Health Council of the Netherlands Gezondheidsraad (GR) Towards an adequate intake of vitamins and minerals
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical testing in colorectal cancer screening of average risk individuals: economic evaluation
2009     Belgian Health Care Knowledge Centre (KCE) Policies for rare diseases and orphan drugs
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Developing a decision aid on HPV-vaccination for young girls and women/ mothers
2009     Belgian Health Care Knowledge Centre (KCE) Endobronchial valves in the treatment of severe pulmonary emphysema: a rapid health technology assessment
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Endobronchial ultrasound for lung cancer diagnosis and staging: a review of the clinical and cost-effectiveness
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Evaluations of child and adolescent psychiatry. (Part 1) - Theory and practice about measurement dimensions, indicators and instruments
2009     Belgian Health Care Knowledge Centre (KCE) Use of point-of-care devices in patients with oral anticoagulation : a Health Technology Assessment
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical tests for colorectal cancer screening: a systematic review of accuracy and compliance
2009     Belgian Health Care Knowledge Centre (KCE) Interspinous implants and pedicle screws for dynamic stabilization of lumbar spine: rapid assessment
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Telemedicine in Stroke Management. Systematic Review
2009     HAYES, Inc. Chromoendoscopy for colonoscopy
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Computed tomography for pediatric patients: review of clinical effectiveness and indications for use
2009     University of York Cognitive behaviour therapy for schizophrenia
2009     Belgian Health Care Knowledge Centre (KCE) Robot-assisted surgery: health technology assessment
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Systematic review of the multidisciplinary combined treatment in peritoneal neoplasms. Radical surgical citoreduction + intraperitoneal chemotherapy +/- hyperthermia (Sugarbaker's technique)
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Tocolysis in preterm labour - a systematic review of evidence-based guidelines, effectiveness and health economic evaluations
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) TomoTherapy, Gamma Knife, and CyberKnife therapies for patients with tumours of the lung, central nervous system, or intra-abdomen: a systematic review of clinical effectiveness and cost-effectiveness
2009     University of York Physical health monitoring for people with schizophrenia or other serious mental illness
2009     Penn Medicine Center for Evidence-based Practice (CEP) Hybrid revascularization
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Low molecular weight heparins: review of the comparative effectiveness for various indications
2009     Penn Medicine Center for Evidence-based Practice (CEP) Reprocessing of surgical drills
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Azacitidine (Vidaza) for the treatment of myelodysplastic syndromes
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Universal development assessment tools for children 18-months of age: a review of the clinical effectiveness and guidelines
2009     Agenzia nazionale per i servizi sanitari regionali (Agenas) Technologies for the identification of osteoporosis
2009     Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for surgical pain management
2009     HAYES, Inc. Combining multislice computed tomography imaging with electroanatomic mapping to guide radiofrequency catheter ablation procedures for atrial fibrillation
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Specialty mattresses for the prevention and management of pressure ulcers: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009     Agenzia nazionale per i servizi sanitari regionali (Agenas) Prostheses for primary total knee replacement in Italy
2009     Belgian Health Care Knowledge Centre (KCE) Use of point-of care devices in patients with oral anticoagulation: a health technology assessment
2009     Penn Medicine Center for Evidence-based Practice (CEP) Venous thromboembolism prophylaxis for bariatric surgery
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Artificial food colours and hyperactivity
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium compared with ipratropium for patients with moderate to severe chronic obstructive pulmonary disease: a review of the clinical effectiveness
2009     Penn Medicine Center for Evidence-based Practice (CEP) Prevention of surgical site infections
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Benzodiazepines for the treatment of post traumatic stress disorder: a review of the clinical effectiveness and guidelines
2009     Agency for Health Technology Assessment in Poland (AHTAPol) Clinical effectiveness analysis of bosentan, epoprostenol, iloprost, sildenafil and treprostinil in treatment of pulmonary arterial hypertension: a systematic review of randomised controlled trials
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Cannabinoids for the treatment of post-traumatic stress disorder: a review of the clinical effectiveness and guidelines
2009     HAYES, Inc. Computerized provider order entry for medications: adult inpatients
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Descemet stripping automated endothelial keratoplasty: a review of the clinical and cost-effectiveness
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Clinical practice guideline on eating disorders
2009     HAYES, Inc. Craniosacral therapy
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Nonmedical secondary prevention of patients with coronary heart disease]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Hyperbaric oxygen therapy for autism: a review of the clinical and cost-effectiveness
2009     VA Technology Assessment Program (VATAP) Health risks from cellular phone use
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Arthroplasty register for Germany]
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Casting for foot orthotics: a review of the clinical and cost-effectiveness
2009     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Smoking cessation among patients in general practice - a health technology assessment]
2009     HAYES, Inc. 3.0 Tesla (3T) Magnetic Resonance Imaging (MRI) for Prostate Cancer
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for mood disorders: a review of the clinical effectiveness
2009     National Institute for Health and Care Excellence (NICE) Topotecan for the treatment of relapsed small-cell lung cancer. NICE technology appraisal guidance 184
2009     HAYES, Inc. Echinacea for prevention or treatment of the common cold